Added to YB: 2026-01-20
Pitch date: 2026-01-17
AVCR.V [neutral]
Avricore Health Inc.
-15.79%
current return
Author Info
No bio for this author
Company Info
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes.
Market Cap
CAD 9.1M
Pitch Price
CAD 0.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.83
P/E
-4.43
EV/Sales
4.46
Sector
Health Care Technology
Category
turnaround
Avricore's Healthtab UK Pivot
AVCR.V (watchlist): Point-of-care testing co pivoting from failed Canada rollout to UK pharmacy partnerships. Expanding London pilot to 70 additional pharmacies, targeting 500+ by end-2026. Dense UK geography advantage vs Canada fragmentation. New CEO focus on execution over hype. Equity raise likely needed 6-18 months creating dilution risk.
Read full article (3 min)